Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y
i
Other names:
EGFR, ERBB, ERBB1, Epidermal growth factor receptor, DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1956
;
4233
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
EGFR-RAD51 fusion (5)
HLA-DRB1-MET fusion (3)
EGFR-SEPTIN14 fusion (2)
KIF5B-MET fusion (2)
MET fusion (2)
MET-ATXN7L1 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
CD47-MET fusion (1)
EHBP1‐MET fusion (1)
KIF5B-MET fusion + MET-CDR2 fusion (1)
MET-TNS3 fusion (1)
MET-TRIM4 fusion (1)
MET-UBE2H fusion (1)
PRKAR1A-MET fusion (1)
RBPMS-MET fusion (1)
STARD3NL-MET fusion (1)
EGFR fusion + RAD51 fusion (0)
EGFR-RAD51 fusion (5)
HLA-DRB1-MET fusion (3)
EGFR-SEPTIN14 fusion (2)
KIF5B-MET fusion (2)
MET fusion (2)
MET-ATXN7L1 fusion (2)
EGFR fusion (1)
EGFR-GRB2 fusion (1)
KIF5B-EGFR fusion (1)
CD47-MET fusion (1)
EHBP1‐MET fusion (1)
KIF5B-MET fusion + MET-CDR2 fusion (1)
MET-TNS3 fusion (1)
MET-TRIM4 fusion (1)
MET-UBE2H fusion (1)
PRKAR1A-MET fusion (1)
RBPMS-MET fusion (1)
STARD3NL-MET fusion (1)
EGFR fusion + RAD51 fusion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y
Lung Adenocarcinoma
EGFR exon 19 deletion + MET amplification + MET D1228H + MET D1228N + MET D1228Y
Lung Adenocarcinoma
osimertinib + cabozantinib tablet
Resistant: C4 – Case Studies
osimertinib + cabozantinib tablet
Resistant
:
C4
osimertinib + cabozantinib tablet
Resistant: C4 – Case Studies
osimertinib + cabozantinib tablet
Resistant
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login